CT arterial enhancement fraction (AEF) for hepatocellular carcinoma (HCC) screening in patients with end-stage liver cirrhosis

Christe, Andreas; Huber, Adrian Thomas; Ebner, Lukas (10 October 2016). CT arterial enhancement fraction (AEF) for hepatocellular carcinoma (HCC) screening in patients with end-stage liver cirrhosis (Unpublished). In: 3th World Congress on Hepatitis. Dubai. 2016.

[img]
Preview
Text
Abstract_CT arterial enhancement fraction Dubaib.pdf - Other
Available under License BORIS Standard License.

Download (70kB) | Preview

Item Type:

Conference or Workshop Item (Abstract)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Institute of Diagnostic, Interventional and Paediatric Radiology

UniBE Contributor:

Christe, Andreas; Huber, Adrian Thomas and Ebner, Lukas

Subjects:

600 Technology > 610 Medicine & health

Language:

English

Submitter:

Karin Hofmann

Date Deposited:

21 Apr 2017 17:51

Last Modified:

21 Apr 2017 17:51

BORIS DOI:

10.7892/boris.94476

URI:

https://boris.unibe.ch/id/eprint/94476

Actions (login required)

Edit item Edit item
Provide Feedback